Biomarkers Improve Odds Of Approval, BIO Study Finds
Executive Summary
BIO/Biomedtracker analysis strengthens the case for expanded use of drug development tools like biomarkers with finding that well-defined patient populations in clinical trials are associated with greater likelihood of approval.